OLADIPO OLALEYE: Open Payments
NPI 1467888529 · WINDSOR MILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 9 payments from 5 companies in 2025. Trend: 2023 $40 · 2024 $99 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Lundbeck LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA, COBENFY.
Industry payments across MD — which companies pay providers there.
